相关实验视频

Updated: Jan 7, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

血清尿酸,心血管媒介和心房动:针对URAT1向治疗的遗传证据

Chaoyang Lin^1,2, Qianyao Lai^1,2, Enze Fang^1,2

¹Department of Cardiology, Fujian Medical University Union Hospital, Fujian Cardiovascular Medical Center, Fujian Institute of Coronary Artery Disease, Fujian Cardiovascular Research Center, Fuzhou, 350001, People's Republic of China.

Clinical rheumatology

|December 10, 2025

概括

高血清尿酸水平增加了心房动 (AF) 的风险,由高血压和心力衰竭等心血管疾病介导. 抑制URAT1显示出降低AF风险的潜力,独立于这些介质.

科学领域:

心血管遗传学心血管遗传学
代谢性疾病研究研究
药物基因组学药物基因组学

背景情况:

血清尿酸水平升高与心房 (AF) 发病率的增加有关.
连接血清尿酸与AF的确切机制仍然不完全理解.
尿酸降低疗法可能提供一种减轻AF风险的策略.

研究的目的:

阐明将血清尿酸与AF联系起来的因果途径.
在这种关系中确定关键的中间条件 (调解者).
评估尿酸降低药物标在降低AF风险方面的潜力.

主要方法:

全基因组关联研究 (GWAS) 确定了血清尿酸,介质和药物点的遗传变异.
门德尔随机化 (MR) 分析,包括贝叶斯方法,评估了因果关系.
基因组结构方程建模 (Genomic SEM) 支持调解分析.

主要成果:

在血清尿酸和AF之间确立了显著的遗传和因果关系.
确定的主要调解者包括高血压,心力衰竭和冠状动脉疾病.
抑制URAT1证明了对AF的保护作用,在调节介质后仍然存在.

结论:

诸如高血压和心力衰竭等心血管疾病是血清尿酸和AF之间的重要调解者.
抑制URAT1是一种有前途的治疗点,可以降低AF风险.
抑制URAT1的好处超出了已识别的心血管介质.

关键词:

心房动是一种心房动.药物目标是药物目标.调解分析调解分析门德尔的随机化针对URAT1的治疗方法酸盐是一种酸盐.

更多相关视频

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Published on: July 26, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...